STOCK TITAN

NYSE flags SOLAI (NYSE: SLAI) for low market cap and equity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SOLAI Limited received an additional notice from the NYSE stating it is not in compliance with continued listing standards because its 30‑day average market capitalization and its stockholders’ equity were each below US$50 million.

The company has 90 days from the April 27, 2026 notice to submit a business plan showing how it will regain compliance within 18 months. Its ADSs remain listed for now but face possible suspension and delisting if the NYSE rejects the plan or if trading levels are deemed “abnormally low,” generally below US$0.10.

SOLAI is already working under a separate NYSE deficiency notice related to maintaining a US$1.00 average share price, and will continue to carry a below‑compliance “.BC” indicator until all standards are met.

Positive

  • None.

Negative

  • Heightened NYSE delisting risk: SOLAI fell below the NYSE’s US$50 million market capitalization and equity thresholds and is also under a separate US$1.00 share‑price deficiency process, increasing the chance its ADSs could ultimately be suspended or delisted if remediation fails.

Insights

NYSE noncompliance heightens delisting risk for SOLAI’s ADSs.

SOLAI Limited now faces NYSE scrutiny on both market capitalization/equity and minimum share price. The notice cites an average market cap under US$50 million over 30 trading days and stockholders’ equity below US$50 million as of December 31, 2025.

The company has 90 days from April 27, 2026 to present a credible plan to regain compliance within 18 months. Acceptance would trigger quarterly NYSE monitoring; rejection could lead to suspension and SEC delisting proceedings. The NYSE can also accelerate delisting if ADS trading falls below US$0.10, which it views as “abnormally low.”

Although operations and SEC reporting continue unchanged, investors face elevated listing risk while SOLAI develops its remediation plan and works through parallel cure periods for both market‑based and price‑based NYSE standards.

Market cap threshold US$50 million Minimum average total market capitalization over 30 trading days
Equity threshold US$50 million Minimum stockholders’ equity as of December 31, 2025
Plan submission period 90 days Time after April 27, 2026 NYSE notice to submit business plan
Compliance window 18 months Period from NYSE notice to regain compliance with criteria
Abnormally low price level US$0.10 NYSE guideline for accelerated delisting of ADSs
Minimum price standard US$1.00 Separate 30‑day average price requirement referenced in January 29, 2026 NYSE letter
Notice date April 27, 2026 Date of NYSE market cap and equity deficiency notice
Measurement date April 24, 2026 Date used to assess average total market capitalization
continued listing standards regulatory
"notice regarding NYSE continued listing standards because, as of April 24, 2026"
Ongoing rules a stock exchange requires a listed company to meet to keep its shares trading publicly, such as minimum share price, market value, timely financial reports, and governance practices. Think of it as a membership checklist for a club: falling short can lead to warnings or removal from the exchange, which can sharply reduce liquidity, investor confidence, and a stock’s value. Investors watch these standards to gauge regulatory risk and the stability of their holdings.
market capitalization financial
"average total market capitalization was less than US$50 million over a consecutive 30 trading-day period"
Market capitalization is the total market value of a company’s outstanding shares, calculated by multiplying the current share price by the number of shares issued. It gives a quick snapshot of a company’s size and how investors value it, influencing perceived risk, index membership, and roughly how much it might cost to buy the whole company — like using a sticker price to compare the relative size and price of different houses.
stockholders’ equity financial
"last reported stockholders’ equity as of December 31, 2025 was less than US$50 million"
Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.
American Depositary Shares financial
"the Company’s American Depositary Shares (“ADSs”) trade at levels viewed to be “abnormally low”"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
NYSE Listed Company Manual regulatory
"In accordance with procedures in the NYSE’s Listed Company Manual, the Company has 90 calendar days"
A NYSE Listed Company Manual is the rulebook that sets the standards and obligations companies must meet to trade on the New York Stock Exchange, covering eligibility, ongoing disclosure, corporate governance and trading procedures. For investors it matters because the manual enforces transparency and minimum safeguards—like a building code for markets—so shareholders can trust that listed companies provide timely information and meet basic financial and governance standards.
forward-looking statements regulatory
"This news release contains forward-looking statements within the meaning of Section 21E"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2026

 

Commission File Number: 001-36206

 

SOLAI Limited

 

428 South Seiberling Street

Akron, Ohio 44306

United States of America

+1 (346) 204-8537

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x         Form 40-F ¨

 

 

 

 

 

 

TABLE OF CONTENTS

 

Exhibit 99.1 Press release – SOLAI Limited Receives Additional Notice Regarding NYSE Continued Listing Standards

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SOLAI LIMITED
     
  By: /s/ Xianfeng Yang
  Name: Xianfeng Yang
  Title: Chief Executive Officer
     
Date: May 26, 2026    

 

 

 

 

 

Exhibit 99.1

 

SOLAI Limited Receives Additional Notice Regarding NYSE Continued Listing Standards

 

AKRON, Ohio, May 26, 2026 /PRNewswire/ – SOLAI Limited (NYSE: SLAI) (previously traded under “BTCM”) (“SOLAI” or the “Company”), a technology-driven personal AI and digital infrastructure provider, today announced that it received a letter from the New York Stock Exchange (the “NYSE”), dated April 27, 2026, notifying the Company that it was not in compliance with applicable market capitalization and equity criteria (the “Market Cap and Equity Criteria”) in the NYSE’s continued listing standards because, as of April 24, 2026, the Company’s (i) average total market capitalization was less than US$50 million over a consecutive 30 trading-day period, and (ii) last reported stockholders’ equity as of December 31, 2025 was less than US$50 million.

 

In accordance with procedures in the NYSE’s Listed Company Manual, the Company has 90 calendar days following its receipt of the notice to submit a business plan to the NYSE that demonstrates how the Company intends to regain compliance with the Market Cap and Equity Criteria within 18 months of receipt of the notice. The Company has already acknowledged receipt of the notice and intends to develop and submit such a business plan to the NYSE. The business plan will then be reviewed for final disposition by the NYSE. Any outstanding listing or annual fees must be paid in full before the business plan is submitted to and reviewed by the NYSE.

 

If the NYSE accepts the plan, the Company will be subject to quarterly monitoring for compliance with the business plan. If the NYSE does not accept the business plan, the Company will be subject to suspension by the NYSE and delisting by the SEC.

 

Notwithstanding the foregoing, the NYSE may take accelerated delisting action if the Company’s American Depositary Shares (“ADSs”) trade at levels viewed to be “abnormally low,” which the NYSE generally views as trading below US$0.10.

 

The NYSE notice does not affect the Company’s business operations, its U.S. Securities and Exchange Commission reporting requirements, or its contractual obligations. The notice has no immediate impact on the listing of the Company’s ADSs, which will continue to be listed and traded on the NYSE, subject to compliance with other NYSE continued listing standards, including the conditions set forth in the NYSE’s letter dated January 29, 2026 for noncompliance with the US$1.00 over a 30 trading-day average price standard, and other rights of the NYSE to delist the ADSs. The cure periods under the different standards work independently of each other, and the NYSE could take delisting action under one standard while the Company remains in the cure period for the other. The Company will continue to be included in the list of NYSE noncompliant issuers, and the below compliance (“.BC”) indicator will continue to be disseminated with the Company’s ticker symbol(s). The website posting and .BC indicator will be removed when the Company has regained compliance with all applicable continued listing standards.

 

About SOLAI Limited

 

SOLAI Limited (previously known as “BIT Mining Limited”) (NYSE: SLAI) (previously traded under “BTCM”) is a technology-driven personal AI and digital infrastructure provider. Building upon its historical legacy in digital asset mining and blockchain network operations, the Company is leveraging extensive experience in large-scale hardware deployment, data center operations, and high-performance computing to build the foundational infrastructure for personal AI computing and digital asset ecosystems globally.

 

Forward-Looking Statements

 

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “going forward,” “outlook” and similar statements. These forward-looking statements include, without limitation, statements regarding the Company’s plans to develop and submit a business plan to the NYSE, satisfy applicable requirements under the NYSE Listed Company Manual, and regain compliance with the NYSE’s continued listing standards. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

 

 

 

 

For further information:

 

SOLAI Limited

ir@solai.com

ir.solai.com

www.solai.com

 

Christensen Advisory

Jason Ng

Tel: +852-2117-0861

Email: solai@christensencomms.com

 

 

 

FAQ

Why did SOLAI Limited (SLAI) receive a new NYSE noncompliance notice?

SOLAI received the notice because its 30‑day average market capitalization was under US$50 million and its stockholders’ equity as of December 31, 2025 was also below US$50 million, breaching NYSE continued listing standards for market cap and equity.

How long does SOLAI (SLAI) have to regain NYSE listing compliance?

SOLAI has 90 days from the April 27, 2026 NYSE notice to submit a business plan and up to 18 months from that notice date to regain compliance with the NYSE’s market capitalization and equity criteria under its continued listing standards.

What happens if the NYSE rejects SOLAI’s SLAI compliance plan?

If the NYSE does not accept SOLAI’s business plan, the company’s ADSs may be suspended from trading and become subject to delisting proceedings by the SEC, potentially removing SOLAI from the NYSE if no alternative remedy is achieved in time.

Does the NYSE notice immediately affect trading of SOLAI (SLAI) ADSs?

The notice does not immediately affect trading. SOLAI’s ADSs remain listed on the NYSE, but they carry a below‑compliance “.BC” indicator and remain subject to potential suspension or delisting if the company fails to regain compliance with all applicable listing standards.

How do SOLAI’s NYSE price and market cap issues interact for SLAI shares?

SOLAI is addressing two separate NYSE standards: market cap/equity and a US$1.00 average share‑price requirement. Cure periods run independently, and the NYSE could delist under one standard while the company remains in the cure period for the other.

When could SOLAI (SLAI) face accelerated NYSE delisting action?

The NYSE may take accelerated delisting action if SOLAI’s ADSs trade at levels it considers “abnormally low,” which it generally views as prices below US$0.10, even if the company is still within the standard cure period for other listing deficiencies.

Filing Exhibits & Attachments

1 document